We do research in microbiology and microbial ecology, primarily focusing on antibiotic resistance, pathogenesis and interactions in bacterial communities using data-driven analysis and experiments

Our research focus is on reprogramming cellular metabolism to produce biochemicals, fuels and pharmaeuceticals.

Our research focus is on developing microbial drug discovery and production platforms.

We are focusing on immunological mechanisms and tools for prevention, diagnosis and treatment of autoimmune diseases especially in children with type 1 diabetes and/or celiac disease.

Through model-driven analysis of experimental data we aim to understand, predict and engineer biology, among others in baker’s and oleaginous yeasts and antibiotic producing bacteria.

We work on signaling and regulation in bacterial cells, focusing in particular on regulatory phenomena based on protein phosphorylation.

We look into the roles of oxidants on physiology, especially the roles of peroxiredoxin antioxidants on proteostasis, signaling and aging. Knowledge gained is used to benefit health and engineering.

Our research focus is on systems biology of metabolism. The yeast Saccharomyces cerevisiae is our key organism for experimental research.

We are combining methods of molecular and cell biology, biochemistry, bioinformatics and systems biology with the scope to study how cells regulate aging and death pathways.

Our research aims to explore endotypes in complex diseases to advance personalized and predictive medicine. We use computational methods to model human pathophysiology using clinical and molecular data.

We develop and apply synthetic biology tools to generate yeast cell factories for the sustainable production of proteins and chemicals as well as to create whole-cell biosensors.

We apply best practices of computational biology together with machine learning to understand the behavior of metabolic networks at single and multispecies levels.